Cargando…

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most common type of RCC can be classified into three subtypes including clear cell, papillary and chromophobe. ccRCC (the Clear Cell Renal Cell Carcinoma) is the most frequent form and shows variations in genetics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Peng, Liu, Jia-Li, Pei, Shi-Mei, Wu, Chang-Peng, Yang, Kai, Wang, Shu-Peng, Wu, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851245/ https://www.ncbi.nlm.nih.gov/pubmed/29534679 http://dx.doi.org/10.1186/s12885-018-4176-1

Ejemplares similares

Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma
por: Li, Zongcheng, et al.
Publicado: (2016)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Chen, Shao-An, et al.
Publicado: (2023)

Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories
por: Pan, Xiu-wu, et al.
Publicado: (2023)

Integrated bulk and single-cell transcriptome data identify clinically relevant cell populations in clear cell renal cell carcinoma
por: Zhang, Pingbao, et al.
Publicado: (2023)

Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Tan, Ying, et al.
Publicado: (2020)

Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways
por: Lin, Peng, et al.
Publicado: (2021)

Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021)

Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma
por: Wu, Han, et al.
Publicado: (2021)

Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
por: Tan, Tuan Zea, et al.
Publicado: (2019)

Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders
por: Gu, Tongjun, et al.
Publicado: (2019)

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)
por: Zeng, Xing, et al.
Publicado: (2022)

An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma
por: Wu, Zhulin, et al.
Publicado: (2020)

Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus
por: Wang, Xiang-Ming, et al.
Publicado: (2020)

Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Xu, Dengyong, et al.
Publicado: (2020)

Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2022)

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
por: Clark, David J., et al.
Publicado: (2019)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2021)

Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell Carcinoma
por: Wang, Shichao, et al.
Publicado: (2021)

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
por: Wang, Yi, et al.
Publicado: (2022)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
por: Czyzyk-Krzeska, Maria F., et al.
Publicado: (2021)

Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Huang, Hao, et al.
Publicado: (2021)

Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
por: Huang, Yi, et al.
Publicado: (2019)

Author Correction: Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders
por: Gu, Tongjun, et al.
Publicado: (2019)

Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma
por: Zhang, Chuanjie, et al.
Publicado: (2022)

RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition
por: Shao, I‐Hung, et al.
Publicado: (2023)

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes
por: Anderson, Joshua C., et al.
Publicado: (2015)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma
por: Peng, Qiliang, et al.
Publicado: (2020)

Relevance and Therapeutic Possibility of PTEN-Long in Renal Cell Carcinoma
por: Wang, Hui, et al.
Publicado: (2015)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment
por: Niu, Shaoxi, et al.
Publicado: (2021)

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
por: Şenbabaoğlu, Yasin, et al.
Publicado: (2016)

Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels
por: Sim, Mei Yi, et al.
Publicado: (2017)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
por: Wu, Zhulin, et al.
Publicado: (2020)

Integrative computational approach identifies immune‐relevant biomarkers in ulcerative colitis
por: He, Tianzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hicc1649ni7qd4daadhbeiikp3